We are Elvium Life Sciences, a
pharmaceutical company passionately
committed to improving the health
and quality of life of Canadians
through innovative medicines in
specific therapeutic disease areas
of need and importance.
Elvium Life Sciences focuses on our
existing products in the areas of
CNS (ADHD) and ophthalmic
conditions while continuing to seek
to deliver new therapies to meet
the needs of Canadians. View our
products to learn more.
